30 related articles for article (PubMed ID: 16536802)
21. Psoriatic skin expresses the transcription factor Gli1: possible contribution of decreased neurofibromin expression.
Endo H; Momota Y; Oikawa A; Shinkai H
Br J Dermatol; 2006 Apr; 154(4):619-23. PubMed ID: 16536802
[TBL] [Abstract][Full Text] [Related]
22. Neurofibromatosis type 1 (NF1) gene: Beyond café au lait spots and dermal neurofibromas.
Peltonen S; Kallionpää RA; Peltonen J
Exp Dermatol; 2017 Jul; 26(7):645-648. PubMed ID: 27622733
[TBL] [Abstract][Full Text] [Related]
23. Aberrant signalling and transcription factor activation as an explanation for the defective growth control and differentiation of keratinocytes in psoriasis: a hypothesis.
McKenzie RC; Sabin E
Exp Dermatol; 2003 Aug; 12(4):337-45. PubMed ID: 12930288
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA profiling of psoriatic skin identifies 11 miRNAs associated with disease severity.
Solvin ÅØ; Chawla K; Olsen LC; Hegre SA; Danielsen K; Jenssen M; Furberg AS; Saunes M; Hveem K; Saetrom P; Løset M
Exp Dermatol; 2022 Apr; 31(4):535-547. PubMed ID: 34748247
[TBL] [Abstract][Full Text] [Related]
25. Topically Used Herbal Products for the Treatment of Psoriasis - Mechanism of Action, Drug Delivery, Clinical Studies.
Herman A; Herman AP
Planta Med; 2016 Nov; 82(17):1447-1455. PubMed ID: 27574899
[TBL] [Abstract][Full Text] [Related]
26. The therapeutic potential of neurofibromin signaling pathways and binding partners.
Báez-Flores J; Rodríguez-Martín M; Lacal J
Commun Biol; 2023 Apr; 6(1):436. PubMed ID: 37081086
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
30.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
